ClinicalTrials.Veeva

Menu

PET/CT to Identify "Vulnerable" Arterial Plaque

R

Rambam Health Care Campus

Status

Unknown

Conditions

Cancer

Treatments

Device: PET/CT imaging

Study type

Interventional

Funder types

Other

Identifiers

NCT00416065
plaqueCTIL

Details and patient eligibility

About

The purpose of this research is to evaluate the presence, location and intensity of FDG uptake in the large arteries using the new technology of fused PET/CT imaging and to compare FDG uptake with the presence of arterial calcifications as seen on the simultaneously acquired CT, in order to determine if FDG was increases incalcified plaque or in a different location in the arterial wall. we will also evaluate the relationship between FDG localization and future cardiovascular events in out patient population

Sex

All

Ages

50+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients referred for clinical FDG-PET/CT studies
  • Patients 50 yr or older
  • Patients signed informed consent

Exclusion criteria

  • Patients unable or unwilling to tolerate the scan until its completion

Trial contacts and locations

1

Loading...

Central trial contact

Ora Israel, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems